+ All Categories
Home > Documents > The OneTouch Verio Flex helps take the guesswork out of ......diabetes app in the U.S.? ‡ See...

The OneTouch Verio Flex helps take the guesswork out of ......diabetes app in the U.S.? ‡ See...

Date post: 13-Jul-2020
Category:

Documents
Upload: others
View: 0 times
Download: 0 times
Download Report this document
Share this document with a friend
2
The OneTouch Verio Flex ® meter helps take the guesswork out of your numbers in 2 easy steps Before using the OneTouch Verio Flex ® meter to test your blood glucose, carefully read the Owner’s Booklet and inserts that come with the components of the system. In a clinical study, using OneTouch Reveal ® mobile app with the OneTouch Verio Flex ® meter helped 8 out of 10 people see patterns in their blood glucose, enabling them to take action to get back in range * † Interested in the #1 downloaded diabetes app in the U.S.? ‡ See reverse side 9:05 MORE mg/dL 129 Today, 9:05 AM Average 135 mg/dL Readings 58 Readings/Day 4.1 22% High 71% In Range 7% Low Oct 6–Today 14-Day Averages Comparator 9:05 ns ke mg/dL 129 Today, 9:05 AM Average 135 mg/dL Reading ading ding din ding ing n g ding n ng ading n g in s s s s s s s s s s s s s s s s 58 5 58 58 8 8 58 8 8 5 7 7 7 71% 71% 71% 71% 1% % % 71% 1% 7 1% 7 7 1 % In n n n n Ran Ran Ran Ran Ran n n R n n Rang g g g g g ge ge e g ge e g ge g g g ge g g ge g ge g ge g Oct 6–Today 14-Day ges Com T In Averag * During a 3 month period in a 24-week study conducted in the UK in 2016 with 128 patients (79 Type 1 and 49 Type 2), 82% of 62 respondents agreed the OneTouch Reveal ® mobile app detected patterns and 80% of 51 respondents agreed they were able to correct the underlying cause of these patterns to get their blood sugar back into range † Treatment decisions should be based on the numerical results and healthcare professionals recommendations and not solely on where results fall within the range limits. ‡ Research2Guidance Diabetes App Market total downloads data Jan-Sept 2019. © 2020 LifeScan IP Holdings, LLC US-VFX-1900078 Step 2 And that’s it. Your results appear on screen. Our ColorSure ® technology will instantly show if your results are in or out of range. Insert a OneTouch Verio ® test strip Step 1 2 Apply blood to either side of the strip + Virtually pain-free testing =
Transcript
Page 1: The OneTouch Verio Flex helps take the guesswork out of ......diabetes app in the U.S.? ‡ See reverse side 9:05 MORE mg/dL 129 Today, 9:05 AM Average 135 mg/dL Readings 58 Readings/Day

The OneTouch Verio Flex®

meter

helps take the guesswork out of

your numbers in 2 easy steps

Before using the OneTouch Verio Flex® meter to test your blood glucose, carefully read the

Owner’s Booklet and inserts that come with the components of the system.

In a clinical study, using OneTouch Reveal®

mobile app with the OneTouch Verio Flex®

meter helped 8 out of 10 people see patterns

in their blood glucose, enabling them to take

action to get back in range*†

Interested in the

#1 downloaded

diabetes app

in the U.S.?‡

See reverse side

9:05

MORE

mg/dL

129Today, 9:05 AM

Average

135 mg/dL

Readings

58Readings/Day

4.1

22%High

71%In Range

7%Low

Oct 6–Today

14-Day

Averages Comparator

9:05

ns

ke

mg/dL

129Today, 9:05 AM

Average

135 mg/dL

ReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingReadingssssssssssssssssss

58585858585858585858

71%71%71%71%71%71%71%71%71%71%71%71%71%71%71%71%71%71%In RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn RanIn Rangegegegegegegegegegegegegegegegegegegegegegegegegegegegegegegegege

Oct 6–Today

14-Day

Averages Compara

Today, 9:05

In Ran

Averages

* During a 3 month period in a 24-week study conducted in the UK in 2016 with 128 patients (79 Type 1 and 49 Type 2), 82% of 62 respondents agreed the OneTouch Reveal® mobile app detected patterns and 80% of 51 respondents agreed they were able to correct the underlying cause of these patterns to get their blood sugar back into range

† Treatment decisions should be based on the numerical results and healthcare professionals recommendations and not solely on where results fall within the range limits.

‡ Research2Guidance Diabetes App Market total downloads data Jan-Sept 2019.

© 2020 LifeScan IP Holdings, LLC US-VFX-1900078

Step

2And that’s it.

Your results

appear on screen.

Our ColorSure®

technology will

instantly show if

your results are

in or out of range.

Insert a

OneTouch Verio®

test strip

Step

1 2

Apply blood

to either side of

the strip

+Virtually

pain-free testing

=

Page 2: The OneTouch Verio Flex helps take the guesswork out of ......diabetes app in the U.S.? ‡ See reverse side 9:05 MORE mg/dL 129 Today, 9:05 AM Average 135 mg/dL Readings 58 Readings/Day

Sync data, seamlessly, from your

OneTouch Verio Flex®

meter directly to

your smartphone. Let’s get started....

∞ Visit the app store on your mobile device, search

“OneTouch Reveal”, then install the app

∞ Press the OK button to turn your meter on

∞ Press the OK and > buttons at the same

time to activate Bluetooth®

Don't forget to also

activate Bluetooth® on

your mobile device.

1. Download the FREE OneTouch Reveal® app

2. Activate Bluetooth® on your OneTouch Verio Flex® meter

(Optional) Share data with your Care Team

∞ After setup, tap MORE and select Connections

∞ Tap Add a Clinic and enter the Clinic Code

provided by your Care Team and follow

the rest of the on-screen instructions

Enter Clinic Code

Discover more at OneTouch.com or call the Customer Care Team at 1-866-693-0599

Now you're ready to test and sync!

You can also view

your account on

your computer at

OneTouchReveal.com

∞ Open the OneTouch Reveal® app on your mobile

device and follow the on-screen instructions

∞ When prompted, enter the PIN shown on your

meter screen into your mobile device and tap Pair

Example of a PIN number

3. Connect 9:05

MORE

mg/dL

129Today, 9:05 AM

Average

135 mg/dL

Readings

58Readings/Day

4.1

22%High

71%In Range

7%Low

Oct 6–Today

14-Day

Averages Comparator

9:05

e

ir

mg/dL

129Today, 9:05 AM

Average

135 mg/dL

ReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadingsReadings

5858585858585858585858

71%71%71%71%71%71%71%71%71%71%71%71%71%71%71%In RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn RangeIn Range

Oct 6–Today

14-Day

Averages Compara

Today, 9:05 AM

In Range

Averages

Apple and the Apple logo are trademarks of Apple Inc., registered in the US and other countries. App Store is a service mark

of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. The Bluetooth® word mark and logos are

registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by LifeScan Scotland Ltd. and its affiliates is

under license. Other trademarks and trade names are those of their respective owners.

© 2020 LifeScan IP Holdings, LLC US-VFX-1900078


Recommended
s50a01cecc1a00a9c.jimcontent.com€¦ · GBA G CASUAL NIVEL DE DECISIÓN > 6.5 0/0 > 126 mg/dL > 200 mg/dL > 200 mg/dL OBSERVACIONES Método Certificado NGSP Ayuno de 8 hrs Carga

s50a01cecc1a00a9c.jimcontent.com€¦ · GBA G CASUAL NIVEL DE DECISIÓN > 6.5 0/0 > 126 mg/dL > 200 mg/dL > 200 mg/dL OBSERVACIONES Método Certificado NGSP Ayuno de 8 hrs Carga

Documents

LDL-C target levels (mg/dL) 2 RF:

LDL-C target levels (mg/dL) 2 RF:

Documents

Clinical aspects of common mineral disorders. hypocalcemia Normal [Ca2+] total = 8.5-10.5 mg/dl (2.12-2.62 mmol/L) Normal [Ca2+] ion = 4.65-5.25 mg/dL.

Clinical aspects of common mineral disorders. hypocalcemia Normal [Ca2+] total = 8.5-10.5 mg/dl (2.12-2.62 mmol/L) Normal [Ca2+] ion = 4.65-5.25 mg/dL.

Documents

Automat ic Analyzer Reagents Lipids - Veredus …...addition concentration 20 mg/dL 500 mg/dL 50 mg/dL 500 U/mL 5000mg/dL measurement value Base Serum 104.0 104.0 105.0 108.0 118.0

Automat ic Analyzer Reagents Lipids - Veredus …...addition concentration 20 mg/dL 500 mg/dL 50 mg/dL 500 U/mL 5000mg/dL measurement value Base Serum 104.0 104.0 105.0 108.0 118.0

Documents

PowerPoint - 4x3 Arial NLA May 16 2019.pdfLDL-C reduction calculated 82 mg/dL 56 mg/dL 57 mg/dL Estimated 5 year MACE RRR1 44% 30% 31%. Title: PowerPoint - 4x3 Arial Author: Peter

PowerPoint - 4x3 Arial NLA May 16 2019.pdfLDL-C reduction calculated 82 mg/dL 56 mg/dL 57 mg/dL Estimated 5 year MACE RRR1 44% 30% 31%. Title: PowerPoint - 4x3 Arial Author: Peter

Documents

 · >25.0 mg/dL >1.17 mg/dL >1.20 mg/dL Provider Ordering Provider Account No: 123A Notes ResultS Name Accession No: Report Date & Time: 3.152017 04:00 PM FINAL REPORT Notes 10.01.

 · >25.0 mg/dL >1.17 mg/dL >1.20 mg/dL Provider Ordering Provider Account No: 123A Notes ResultS Name Accession No: Report Date & Time: 3.152017 04:00 PM FINAL REPORT Notes 10.01.

Documents

CK-MB - Wiener lab...867022324 / 00 p. 2/12 interferencias por bilirrubina hasta 390 mg/l (39 mg/dl), triglicéridos hasta 3,0 g/l (300 mg/dl) ni hemoglobina hasta 0,06 g/dl (60 mg/dl)

CK-MB - Wiener lab...867022324 / 00 p. 2/12 interferencias por bilirrubina hasta 390 mg/l (39 mg/dl), triglicéridos hasta 3,0 g/l (300 mg/dl) ni hemoglobina hasta 0,06 g/dl (60 mg/dl)

Documents

tlu{tu}.f Case Report · Anisocytosis 3+ Hypochromia 3+ Microcytic &t Serum albumin 1.53 g/dl, globulin 1 .19 g/dl Total calcium 1.76 mg/dl (correct Ca 3.73), Magnesium 0.57 mg/dl

tlu{tu}.f Case Report · Anisocytosis 3+ Hypochromia 3+ Microcytic &t Serum albumin 1.53 g/dl, globulin 1 .19 g/dl Total calcium 1.76 mg/dl (correct Ca 3.73), Magnesium 0.57 mg/dl

Documents

Achieving New Treatment Goals for LDL-C: Strategies for ... · 2 3 4 Atorvastatin Placebo 132 mg/dL 126 mg/dL 89 mg/dL Moderate Risk Lower LDL-C ↓CV Events 3% Placebo 1.9% Treatment

Achieving New Treatment Goals for LDL-C: Strategies for ... · 2 3 4 Atorvastatin Placebo 132 mg/dL 126 mg/dL 89 mg/dL Moderate Risk Lower LDL-C ↓CV Events 3% Placebo 1.9% Treatment

Documents

Clinical Policy: Evolocumab (Repatha)...a) ≥ 190 mg/dL for genetically mediated primary hyperlipidemias; b) ≥ 220 mg/dL for non-genetically mediated primary hyperlipidemias; b.

Clinical Policy: Evolocumab (Repatha)...a) ≥ 190 mg/dL for genetically mediated primary hyperlipidemias; b) ≥ 220 mg/dL for non-genetically mediated primary hyperlipidemias; b.

Documents

The OneTouch Verio Flex meter helps take the guesswork out ......diabetes app in the U.S.?‡ See reverse side 9:05 MORE mg/dL 129 Today, 9:05 AM Average 135 mg/dL Readings 58 Readings/Day

The OneTouch Verio Flex meter helps take the guesswork out ......diabetes app in the U.S.?‡ See reverse side 9:05 MORE mg/dL 129 Today, 9:05 AM Average 135 mg/dL Readings 58 Readings/Day

Documents

 · CBC WBC RBC Hb ESR alb. chol. TG BUN 4.6g/dl 2.5g/dl 291 mg/ dl 306 mg 20mg/dl ... 199'2-ËF proliferation < -C, matrix Y IgA silent acute purpura purpura

 · CBC WBC RBC Hb ESR alb. chol. TG BUN 4.6g/dl 2.5g/dl 291 mg/ dl 306 mg 20mg/dl ... 199'2-ËF proliferation < -C, matrix Y IgA silent acute purpura purpura

Documents

CASE REPORT - SciELO · abdomen, painful at palpation. Laboratory tests showed Ht 25.9%, Hb 9.2g/dL, WBC 43,800/mm3, with 78% neutrophils, creati-nine 2.9 mg/dL, urea 84.7 mg/dL,

CASE REPORT - SciELO · abdomen, painful at palpation. Laboratory tests showed Ht 25.9%, Hb 9.2g/dL, WBC 43,800/mm3, with 78% neutrophils, creati-nine 2.9 mg/dL, urea 84.7 mg/dL,

Documents

eGFRand CystatinC as Predictors of Mortality & Morbidity · Serum Cr GFR 1 3 5 10 Cr = 1.0 mg/dl Cr = 1.5 mg/dl Cr = 2.0 mg/dl Theoretical Curve Issues with Creatinine • It’s

eGFRand CystatinC as Predictors of Mortality & Morbidity · Serum Cr GFR 1 3 5 10 Cr = 1.0 mg/dl Cr = 1.5 mg/dl Cr = 2.0 mg/dl Theoretical Curve Issues with Creatinine • It’s

Documents

An Algorithmic Approach - Insights...• Bilirubin can quench Nma >> falsely low levels • 2.9 mg/dL bilirubin >> 20% reduction • 11.7 mg/dL >> 80% reduction • Hemoglobinemia

An Algorithmic Approach - Insights...• Bilirubin can quench Nma >> falsely low levels • 2.9 mg/dL bilirubin >> 20% reduction • 11.7 mg/dL >> 80% reduction • Hemoglobinemia

Documents

Farmacologia Diabetes mellitus. OBJETIVOS DO TRATAMENTO ExamesValores Glicemia de Jejum 80 – 120 mg/dl Pós-prandial (2h) < 140 mg/dl Hemoglobina Glicosilada.

Farmacologia Diabetes mellitus. OBJETIVOS DO TRATAMENTO ExamesValores Glicemia de Jejum 80 – 120 mg/dl Pós-prandial (2h) < 140 mg/dl Hemoglobina Glicosilada.

Documents

ucm 307467.pdfReference #2 - Script Your Future · Sunday Blood Glucose Time: _____ MG/DL:_____ Time: _____ MG/DL:_____ Time: _____ MG/DL:_____

ucm 307467.pdfReference #2 - Script Your Future · Sunday Blood Glucose Time: _____ MG/DL:_____ Time: _____ MG/DL:_____ Time: _____ MG/DL:_____

Documents

Guía de práctica clínica de diabetesglucemia al azar ≥ 200 mg/dl. 2. Glucemia basal ≥ 126 mg/dl. 3. Glucemia basal a las 2 hrs de un TTOG ≥ 200 mg/dl. 4. HbA1c ≥ 6,5%. Las

Guía de práctica clínica de diabetesglucemia al azar ≥ 200 mg/dl. 2. Glucemia basal ≥ 126 mg/dl. 3. Glucemia basal a las 2 hrs de un TTOG ≥ 200 mg/dl. 4. HbA1c ≥ 6,5%. Las

Documents